These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 114254)

  • 1. Lead decorporation following therapy with the dibutyl ester of diethylenetriaminepentaacetate in the mouse.
    Sorensen EM; Moretti ES; Lindenbaum A
    Bull Environ Contam Toxicol; 1979 Jul; 22(4-5):617-24. PubMed ID: 114254
    [No Abstract]   [Full Text] [Related]  

  • 2. [Routes of elimination of lead in patients with chronic lead poisoning under the effect of complexon therapy with pentacin (CaNa3 DTPA)].
    Iampol'skaia BA; Dashash A
    Gig Tr Prof Zabol; 1968 Mar; 12(3):54-6. PubMed ID: 5729191
    [No Abstract]   [Full Text] [Related]  

  • 3. Attempt on determination of biologically active lead in organism in experimental poisoning.
    Teisinger J; Prerovská I; Sedivec V; Flek J; Roth Z
    Int Arch Arbeitsmed; 1969; 25(3):240-55. PubMed ID: 4981260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental contribution on the question of lead decorporation by chelating agents].
    Catsch A
    Arzneimittelforschung; 1967 Apr; 17(4):493-5. PubMed ID: 5632447
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of chelating agents on the tissue distribution and excretion of lead.
    Hammond PB
    Toxicol Appl Pharmacol; 1971 Feb; 18(2):296-310. PubMed ID: 4998752
    [No Abstract]   [Full Text] [Related]  

  • 6. Ascorbic acid and EDTA treatment of lead toxicity in rats.
    Goyer RA; Cherian MG
    Life Sci; 1979 Jan; 24(5):433-8. PubMed ID: 107387
    [No Abstract]   [Full Text] [Related]  

  • 7. Lead poisoning in dogs: analysis of blood, urine, hair, and liver for lead.
    Zook BC; Kopito L; Carpenter JL; Cramer DV; Shwachman H
    Am J Vet Res; 1972 May; 33(5):903-9. PubMed ID: 4623390
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic chelation therapy in occupational lead poisoning: a review.
    Bridbord K; Blejer HP
    Am Ind Hyg Assoc J; 1977 Oct; 38(10):536-42. PubMed ID: 411363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead poisoning in small animals.
    Clarke EG
    J Small Anim Pract; 1973 Apr; 14(4):183-94. PubMed ID: 4199370
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and therapeutic testing of mono- and dialkyl esters of pentetic (diethylenetriaminepentaacetic) acid for decorporation of polymeric plutonium.
    Guilmette RA; Parks JE; Lindenbaum A
    J Pharm Sci; 1979 Feb; 68(2):194-6. PubMed ID: 423090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation in metal intoxication. XIII. Polyaminocarboxylic acids as chelators in lead poisoning.
    Tandon SK; Behari JR; Singh S
    Bull Environ Contam Toxicol; 1983 May; 30(5):552-8. PubMed ID: 6407551
    [No Abstract]   [Full Text] [Related]  

  • 12. Atomic absorption determination of lead in blood and urine in the presence of EDTA.
    Zinterhofer LJ; Jatlow PI; Fappiano A
    J Lab Clin Med; 1971 Oct; 78(4):664-74. PubMed ID: 5000359
    [No Abstract]   [Full Text] [Related]  

  • 13. Porphyrin metabolism during Versenate therapy in lead poisoning. Intoxication from an unusual source.
    Fromke VL; Lee MY; Watson CJ
    Ann Intern Med; 1969 May; 70(5):1007-12. PubMed ID: 4976891
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the chelating action of CaDTPA Na3 (trisodic and monocalcic salt of ethylen-triaminopentacetic acid) in experimental and human saturnism and in compairison with the action of CaEDTANa2].
    Rossi A
    Folia Med (Napoli); 1967 Jan; 50(1):39-51. PubMed ID: 4972289
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical uses of metal-binding drugs.
    Chenoweth MB
    Clin Pharmacol Ther; 1968; 9(3):365-87. PubMed ID: 4984845
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of dietary factors on the gastrointestinal absorption of lead.
    Garber BT; Wei E
    Toxicol Appl Pharmacol; 1974 Mar; 27(3):685-91. PubMed ID: 4212088
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolism and toxicity of therapeutic chelating agents. X. Excretion of endogenous manganese].
    Nadolny W
    Strahlentherapie; 1971; 141(1):100-5. PubMed ID: 5002888
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion rate of non-chelatable to chelatable lead after CaEDTA injection: a kinetic study in two lead workers.
    Arak S; Murata K; Yokoyama K; Aono H; Yanagihara S; Ushio K
    J Appl Toxicol; 1983 Feb; 3(1):1-5. PubMed ID: 6409955
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental enhancement of lead toxicity by low dietary calcium.
    Six KM; Goyer RA
    J Lab Clin Med; 1970 Dec; 76(6):933-42. PubMed ID: 5485382
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries.
    Goldstein GW; Asbury AK; Diamond I
    Arch Neurol; 1974 Dec; 31(6):382-9. PubMed ID: 4216346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.